
Higher doses of injectable semaglutide have been shown to cause greater weight loss than standard doses with a similar safety profile.
Pharmacy Practice in Focus: Oncology
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.






